Your browser doesn't support javascript.
loading
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Van Bockstal, Mieke R; François, Aline; Altinay, Serdar; Arnould, Laurent; Balkenhol, Maschenka; Broeckx, Glenn; Burguès, Octavio; Colpaert, Cecile; Dedeurwaerdere, Franceska; Dessauvagie, Benjamin; Duwel, Valérie; Floris, Giuseppe; Fox, Stephen; Gerosa, Clara; Hastir, Delfyne; Jaffer, Shabnam; Kurpershoek, Eline; Lacroix-Triki, Magali; Laka, Andoni; Lambein, Kathleen; MacGrogan, Gaëtan Marie; Marchiò, Caterina; Martin Martinez, Maria-Dolores; Nofech-Mozes, Sharon; Peeters, Dieter; Ravarino, Alberto; Reisenbichler, Emily; Resetkova, Erika; Sanati, Souzan; Schelfhout, Anne-Marie; Schelfhout, Vera; Shaaban, Abeer; Sinke, Renata; Stanciu-Pop, Claudia M; van Deurzen, Carolien H M; Van de Vijver, Koen K; Van Rompuy, Anne-Sophie; Vincent-Salomon, Anne; Wen, Hannah Y; Wong, Serena; Bouzin, Caroline; Galant, Christine.
Afiliação
  • Van Bockstal MR; Department of Pathology, Cliniques universitaires Saint-Luc Bruxelles, Woluwé-Saint-Lambert, Belgium. mieke.vanbockstal@saintluc.uclouvain.be.
  • François A; Department of Pathology, Cliniques universitaires Saint-Luc Bruxelles, Woluwé-Saint-Lambert, Belgium.
  • Altinay S; Department of Pathology, University of Health Sciences, Bakirköy Dr. Sadi Konuk Health Application and Research Center, Istanbul, Turkey.
  • Arnould L; Département de Biologie et de Pathologie des Tumeurs, Centre George-François Leclerc, Dijon, France.
  • Balkenhol M; Department of Pathology, Radboud University Medical Center, HB, Nijmegen, The Netherlands.
  • Broeckx G; Department of Pathology, University Hospital Antwerp, Edegem, Belgium.
  • Burguès O; Department of Pathology, Hospital Clínico Universitario de Valencia, València, Spain.
  • Colpaert C; Department of Pathology, AZ Turnhout Campus Sint-Jozef, Turnhout, Belgium.
  • Dedeurwaerdere F; Department of Pathology, AZ Delta, Roeselare, Belgium.
  • Dessauvagie B; Division of Pathology and Laboratory Medicine, Medical School, The University of Western Australia, Crawley, WA, Australia.
  • Duwel V; Anatomical Pathology, PathWest Laboratory Medicine WA, Perth, Australia.
  • Floris G; Department of pathology, AZ Klina Brasschaat, Brasschaat, Belgium.
  • Fox S; Department of Pathology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium.
  • Gerosa C; Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven - University of Leuven, Leuven, Belgium.
  • Hastir D; Department of Pathology, Peter MacCallum Cancer Center and the University of Melbourne, Melbourne, VIC, Australia.
  • Jaffer S; Department of Pathology, University of Cagliari, AOU San Giovanni di Dio, Cagliari, Italy.
  • Kurpershoek E; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
  • Lacroix-Triki M; Department of Pathology, Mount Sinai Hospital and Icahn School of Medicine, New York, NY, USA.
  • Laka A; Pathan BV, PM, Rotterdam, The Netherlands.
  • Lambein K; Department of Pathology, Gustave-Roussy Cancer Campus, Villejuif, France.
  • MacGrogan GM; Department of Pathology, Clinique Notre-Dame de Grâce (CNDG), Gosselies, Belgium.
  • Marchiò C; Department of Pathology, AZ St Lucas Hospital, Ghent, Belgium.
  • Martin Martinez MD; Surgical Pathology Unit, Department of Pathobiology, Institut Bergonié, Bordeaux, France.
  • Nofech-Mozes S; Department of Medical Sciences, University of Turin, Torino, Italy.
  • Peeters D; Pathology Unit, FPO-IRCCS, Candiolo Cancer Institute, Candiolo, Italy.
  • Ravarino A; Institut de Pathologie et de Génétique, Charleroi, Belgium.
  • Reisenbichler E; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada.
  • Resetkova E; Department of Pathology, AZ St Maarten, Mechelen, Belgium.
  • Sanati S; Histopathology, Imaging and Quantification Unit, HistoGeneX, Antwerp, Belgium.
  • Schelfhout AM; Department of Pathology, University of Cagliari, AOU San Giovanni di Dio, Cagliari, Italy.
  • Schelfhout V; Department of Pathology, Yale School of Medicine, Yale New Haven Hospital, New Haven, USA.
  • Shaaban A; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sinke R; Department of Pathology and Lab Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
  • Stanciu-Pop CM; Department of Pathology, Onze-Lieve-Vrouwziekenhuis Aalst, Aalst, Belgium.
  • van Deurzen CHM; Department of Pathology, AZ St Maarten, Mechelen, Belgium.
  • Van de Vijver KK; Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK.
  • Van Rompuy AS; Pathan BV, PM, Rotterdam, The Netherlands.
  • Vincent-Salomon A; Department of Pathology, CHU UCL Namur, Site Godinne, Yvoir, Belgium.
  • Wen HY; Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Wong S; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  • Bouzin C; Department of Pathology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium.
  • Galant C; Pôle de Médicine Diagnostique & Théranostique, INSERM U934, Institut Curie, Paris Cedex 05, France.
Mod Pathol ; 34(12): 2130-2140, 2021 12.
Article em En | MEDLINE | ID: mdl-34218258
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Células Estromais / Microambiente Tumoral / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do norte / Europa / Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Células Estromais / Microambiente Tumoral / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do norte / Europa / Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article